Neurology News and Research

Latest Neurology News and Research

Children who undergo simple emergency surgeries on weekends are more likely to die

Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study.

1 Jul 2014

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Agenus Inc., announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with newly diagnosed glioblastoma multiforme (GBM) who received Agenus' Prophage autologous cancer vaccine added to the standard of care treatment, lived nearly twice as long as expected.

1 Jul 2014

Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

1 Jul 2014

Research could help to reduce health care charges

Recently published findings in Annals of Internal Medicine by Steven Lipshultz, M.D., Wayne State University professor and chair of pediatrics and pediatrician-in-chief at the Children's Hospital of Michigan, part of the Detroit Medical Center, and colleagues could help to reduce health care charges while also protecting childhood cancer survivors from heart ailments caused by drug therapy.

1 Jul 2014

Helsinn Group grants GEN Ilaç anamorelin rights for Turkey

Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.

30 Jun 2014

Amyotrophic lateral sclerosis in veterans: an interview with Milan Michael Karol, The Robert Packard Center for ALS Research at Johns Hopkins

ALS stands for Amyotrophic Lateral Sclerosis, better known as “Lou Gehrig’s Disease”. It is a progressive neurodegenerative disease characterized by the death of motor neurons in the brain and spinal cord.

30 Jun 2014

EMA CHMP recommends marketing authorization for GE's VIZAMYL for PET imaging to detect beta amyloids

GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use. This opinion recommends the granting of a marketing authorisation for VIZAMYL (Flutemetamol F18 injection), a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive impairment.

30 Jun 2014

Increasing clearance of ALS misfolded protein from neurons improves their survival

In work supported by The ALS Association, researchers have shown that increasing the clearance of misfolded protein from neurons improves their survival. The study was published today in the journal Nature Chemical Biology.

30 Jun 2014

Targeting ASIC-related neurotransmission may lead to new therapies for treating drug addiction

University of Iowa researchers have discovered a new form of neurotransmission that influences the long-lasting memory created by addictive drugs, like cocaine and opioids, and the subsequent craving for these drugs of abuse. Loss of this type of neurotransmission creates changes in brains cells that resemble the changes caused by drug addiction.

28 Jun 2014

AHA honors two Mount Sinai Health System experts as "Heart and Stroke Lifesavers"

The American Heart Association has honored two Mount Sinai Health System experts as "Heart and Stroke Lifesavers" for going above and beyond the call of duty in support of the AHA's mission to build lives free of cardiovascular diseases and stroke.

28 Jun 2014

Blocking enzyme Cdk5 could reduce brain damage after stroke

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, UT Southwestern Medical Center research suggests.

27 Jun 2014

DBS improves motor and non motor symptoms of patients with early Parkinson's disease

Deep brain stimulation (DBS) has become a well-recognized non-pharmacologic treatment that improves motor symptoms of patients with early and advanced Parkinson's disease.

26 Jun 2014

Response-adaptive randomization approach can boost patients’ participation in medical studies

It's a classic Catch-22: Medical researchers need to figure out if a promising new treatment is truly better than a current one, by randomly assigning half of a group of patients to get each treatment.

26 Jun 2014

GW clinical trial aims to identify novel modalities to reduce seizures in MTLE patients

A first-of-its-kind clinical trial at the George Washington University Medical Faculty Associates employs low-frequency deep brain stimulation to potentially help reduce epileptic seizures in patients with mesial temporal lobe epilepsy (MTLE) - the most common type of focal epilepsy that often necessitates surgical resection of the temporal lobe, risking memory function.

26 Jun 2014

CHOP launches Fetal Neuroprotection and Neuroplasticity Program

The Children's Hospital of Philadelphia today launched the Fetal Neuroprotection and Neuroplasticity Program. Building on growing evidence of the interaction of heart disease and brain development in the fetus, this Program will systematically investigate innovative therapies to protect brain development and to prevent brain injury as early as possible before birth.

26 Jun 2014

Veterans with traumatic brain injury more likely to develop dementia in later life

Older veterans who have experienced a traumatic brain injury (TBI) are 60 percent more likely to later develop dementia than veterans without TBI, according to a study published in the June 25, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

25 Jun 2014

CHEO, ONF jointly launch first comprehensive pediatric concussion guidelines

Pediatric emergency medicine researchers at the Children's Hospital of Eastern Ontario together with the Ontario Neurotrauma Foundation today launch the first comprehensive pediatric concussion guidelines.

25 Jun 2014

Chronic migraine significantly impacts family relationships and activities

A web-based study of 994 men and women with chronic migraine found that the condition significantly impacts family relationships and activities, including cancelled vacation plans and reduced quality time with partners and children.

25 Jun 2014

Research finding could open new opportunities for treating Huntington's disease

Researchers believe they have learned how mutations in the gene that causes Huntington's disease kill brain cells, a finding that could open new opportunities for treating the fatal disorder. Scientists first linked the gene to the inherited disease more than 20 years ago

24 Jun 2014

Mersana and Merck KGaA develop next-generation antibody-drug conjugates

Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).

24 Jun 2014

Neurology News and Research

Latest Neurology News and Research

Children who undergo simple emergency surgeries on weekends are more likely to die

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Research could help to reduce health care charges

Helsinn Group grants GEN Ilaç anamorelin rights for Turkey

Amyotrophic lateral sclerosis in veterans: an interview with Milan Michael Karol, The Robert Packard Center for ALS Research at Johns Hopkins

EMA CHMP recommends marketing authorization for GE's VIZAMYL for PET imaging to detect beta amyloids

Increasing clearance of ALS misfolded protein from neurons improves their survival

Targeting ASIC-related neurotransmission may lead to new therapies for treating drug addiction

AHA honors two Mount Sinai Health System experts as "Heart and Stroke Lifesavers"

Blocking enzyme Cdk5 could reduce brain damage after stroke

DBS improves motor and non motor symptoms of patients with early Parkinson's disease

Response-adaptive randomization approach can boost patients’ participation in medical studies

GW clinical trial aims to identify novel modalities to reduce seizures in MTLE patients

CHOP launches Fetal Neuroprotection and Neuroplasticity Program

Veterans with traumatic brain injury more likely to develop dementia in later life

CHEO, ONF jointly launch first comprehensive pediatric concussion guidelines

Chronic migraine significantly impacts family relationships and activities

Research finding could open new opportunities for treating Huntington's disease

Mersana and Merck KGaA develop next-generation antibody-drug conjugates

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Neurology News and Research

Latest Neurology News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in